Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Dec;24(6):1093–1097. doi: 10.1128/jcm.24.6.1093-1097.1986

Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.

C H Sherlock, R L Ashley, M L Shurtleff, K D Mack, L Corey
PMCID: PMC269105  PMID: 3023439

Abstract

We evaluated the type specificity of complement-fixing (CF) antibody against the AG-4 early antigen of herpes simplex virus (HSV) type 2 (HSV-2) by comparing a commercial AG-4 CF kit (Simplex-2; Gene Link Australia, Inc., Princeton, N.J.) with quantal microneutralization (MN) and absorption-Western blotting in testing sera from patients with and without a history of genital herpes. Sera characterized as HSV type 1 (HSV-1) or HSV-2 positive or negative by MN were selected and tested by CF, and those with discordant results were further analyzed for specific antibodies by absorption with HSV-1 or HSV-2 antigen and Western blotting with heterologous HSV proteins. A total of 34 of 42 (81%) sera HSV-2 positive by MN, 19 of 43 (44%) sera HSV-1 positive by MN, and 0 of 19 sera negative by MN were positive by CF. Absorption-Western blotting showed that 12 of 18 (67%) sera HSV-1 positive by MN but positive by CF had no HSV-2-specific antibody and that all 7 sera HSV-2 positive by MN but negative by CF had HSV-2-specific antibody. When MN and absorption-Western blotting data were combined to analyze patients with no history of genital herpes, 7 of 19 (37%) with no HSV-2-specific antibody were positive by CF, and 7 of 27 (26%) with HSV-2-specific antibody were negative by CF. The positive and negative predictive values for the CF test were 78 and 75%, respectively, in this group. The presence of antibody to the HSV AG-4 antigen does not discriminate sufficiently between HSV-1- and HSV-2-infected patients to be of value in predicting HSV-2 infection in the absence of symptomatic disease.

Full text

PDF
1093

Images in this article

1095Image
on p.1095

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arsenakis M., Georgiou G. M., Welsh J. K., Cauchi M. N., May J. T. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2. Int J Cancer. 1980 Jan 15;25(1):67–71. doi: 10.1002/ijc.2910250109. [DOI] [PubMed] [Google Scholar]
  2. Arsenakis M., May J. T. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients. Infect Immun. 1981 Jul;33(1):22–28. doi: 10.1128/iai.33.1.22-28.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arsenakis M., May J. T. Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test. Br J Vener Dis. 1982 Feb;58(1):48–51. doi: 10.1136/sti.58.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arvin A. M., Koropchak C. M., Yeager A. S., Pereira L. Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody. Infect Immun. 1983 Apr;40(1):184–189. doi: 10.1128/iai.40.1.184-189.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Aurelian L., Strnad B. C., Smith M. F. Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer. Cancer. 1977 Apr;39(4 Suppl):1834–1849. doi: 10.1002/1097-0142(197704)39:4+<1834::aid-cncr2820390816>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  6. Balachandran N., Harnish D., Killington R. A., Bacchetti S., Rawls W. E. Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol. 1981 Aug;39(2):438–446. doi: 10.1128/jvi.39.2.438-446.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bernstein D. I., Bryson Y. J., Lovett M. A. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol. 1985 Mar;15(3):251–263. doi: 10.1002/jmv.1890150306. [DOI] [PubMed] [Google Scholar]
  8. Bernstein D. I., Lovett M. A., Bryson Y. J. Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med. 1984 Dec;77(6):1055–1060. doi: 10.1016/0002-9343(84)90188-8. [DOI] [PubMed] [Google Scholar]
  9. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  10. Eberle R., Courtney R. J. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect Immun. 1981 Mar;31(3):1062–1070. doi: 10.1128/iai.31.3.1062-1070.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Evans L. A., Sheppard M., May J. T. Analysis of the HSV-2 early AG-4 antigen. Arch Virol. 1985;85(1-2):13–23. doi: 10.1007/BF01317002. [DOI] [PubMed] [Google Scholar]
  12. Gershoni J. M., Palade G. E. Protein blotting: principles and applications. Anal Biochem. 1983 May;131(1):1–15. doi: 10.1016/0003-2697(83)90128-8. [DOI] [PubMed] [Google Scholar]
  13. Honess R. W., Watson D. H. Unity and diversity in the herpesviruses. J Gen Virol. 1977 Oct;37(1):15–37. doi: 10.1099/0022-1317-37-1-15. [DOI] [PubMed] [Google Scholar]
  14. Lee F. K., Coleman R. M., Pereira L., Bailey P. D., Tatsuno M., Nahmias A. J. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol. 1985 Oct;22(4):641–644. doi: 10.1128/jcm.22.4.641-644.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Marsden H. S., Buckmaster A., Palfreyman J. W., Hope R. G., Minson A. C. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol. 1984 May;50(2):547–554. doi: 10.1128/jvi.50.2.547-554.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McClung H., Seth P., Rawls W. E. Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2. Am J Epidemiol. 1976 Aug;104(2):192–201. doi: 10.1093/oxfordjournals.aje.a112289. [DOI] [PubMed] [Google Scholar]
  17. Nahmias A. J., Josey W. E., Naib Z. M., Luce C. F., Duffey A. Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. Am J Epidemiol. 1970 Jun;91(6):539–546. doi: 10.1093/oxfordjournals.aje.a121165. [DOI] [PubMed] [Google Scholar]
  18. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med. 1973 Sep 27;289(13):667–674. doi: 10.1056/NEJM197309272891305. [DOI] [PubMed] [Google Scholar]
  19. Ozaki Y., Ishiguro T. Relationship between type specific antibodies to herpes simplex virus and type specificity in human sera. J Med Virol. 1983;12(2):103–109. doi: 10.1002/jmv.1890120204. [DOI] [PubMed] [Google Scholar]
  20. Rawls W. E., Iwamoto K., Adam E., Melnick J. L. Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol. 1970 Mar;104(3):599–606. [PubMed] [Google Scholar]
  21. Reeves W. C., Corey L., Adams H. G., Vontver L. A., Holmes K. K. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981 Aug 6;305(6):315–319. doi: 10.1056/NEJM198108063050604. [DOI] [PubMed] [Google Scholar]
  22. Smith C. C., Aurelian L. Proteins of herpesvirus type 2. V. Isolation and immunologic characterization of two viral proteins in a virus-specific antigenic fraction. Virology. 1979 Oct 15;98(1):255–260. doi: 10.1016/0042-6822(79)90544-0. [DOI] [PubMed] [Google Scholar]
  23. Smith I. W., Peutherer J. F., MacCallum F. O. The incidence of Herpesvirus hominis antibody in the population. J Hyg (Lond) 1967 Sep;65(3):395–408. doi: 10.1017/s0022172400045915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sullivan-Bolyai J., Hull H. F., Wilson C., Corey L. Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates. JAMA. 1983 Dec 9;250(22):3059–3062. [PubMed] [Google Scholar]
  25. Wentworth B. B., Alexander E. R. Seroepidemiology of infectious due to members of the herpesvirus group. Am J Epidemiol. 1971 Nov;94(5):496–507. doi: 10.1093/oxfordjournals.aje.a121347. [DOI] [PubMed] [Google Scholar]
  26. Zezulak K. M., Spear P. G. Characterization of a herpes simplex virus type 2 75,000-molecular-weight glycoprotein antigenically related to herpes simplex virus type 1 glycoprotein C. J Virol. 1983 Sep;47(3):553–562. doi: 10.1128/jvi.47.3.553-562.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zweig M., Showalter S. D., Bladen S. V., Heilman C. J., Jr, Hampar B. Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants. J Virol. 1983 Jul;47(1):185–192. doi: 10.1128/jvi.47.1.185-192.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES